Bruker
製品とソリューション アプリケーション サービス ニュースとイベント キャリア 企業情報
少なくとも2文字を使用してください (現在1文字を使用しています) 。

Languages

Comparative assessment of mAb higher order structure in biopharmaceutical development using novel NMR and chemometric analysis
Comparative assessment of mAb higher order structure in biopharmaceutical development using novel NMR and chemometric analysis
Webinar

Comparative assessment of mAb higher order structure in biopharmaceutical development using novel NMR and chemometric analysis

Watch On Demand

Webinar Overview

Developments in pulse sequences and instrumentation along with the incorporation of chemometric tools permit NMR spectroscopy to report comparative metrics for higher order structure analysis (HOS) of intact monoclonal antibodies (mAbs). These 1D and 2D NMR chemometric methods can be used in different applications, including forced degradation HOS studies on mAbs, given the high sensitivity and resolution of the technique.

This presentation was part of the Well Characterized Biologics 2021 Conference program.

October 26, 2021

Watch On Demand

Key Learning Topics

  • Importance of biologics and NMR in the pharmaceutical industry
  • Chemometric tools in NMR HOS comparability
  • Case Study: FD study of adalimumab and trastuzumab

Who should attend

The webinar is aimed for those working in the pharmaceutical industry, especially in drug development and production of pharmaceuticals and biopharmaceuticals. Laboratory managers, heads of R&D, analytical development, quality control and manufacturing.

Additionally, the webinar is also of interest to those academics collaborating with pharmaceutical industry and to other industries who face challenges in formulating both solid and liquid mixtures.

Speakers

Dr. Victor Beaumont

Strategic Market Development Specialist, Bruker BioSpin 

Victor has studied and applied NMR techniques throughout his undergraduate studies at the University at Buffalo (Dr. Thomas Szyperski) and PhD program at Yale University (Dr. Patrick Loria). He later joined Pfizer as an NMR specialist for biotherapeutic structure characterization moving then to project management of analytical laboratory automation. His passion is in improving the quality of life and working efficiencies of society by facilitating and contributing high-quality scientific innovation focused on state-of-the-art NMR characterization of novel therapeutic modalities. At Bruker, he is dedicated to working with scientists in understanding the challenges and needs of the industry to expand NMR applications and technology.

Registration

Input value is invalid.

Are you already in contact with your Bruker representative regarding any product inquiries?

We constantly want to improve our service for our customers. In answering the following question you help us to serve your needs even better in the future: What best describes your situation?

By ticking this box, I agree to receive, from time to time, emails from Bruker and its affiliates within the Bruker Group on upcoming events, webinars, our products and services, surveys and Bruker's corporate news.
I can unsubscribe at any time, by contacting Bruker or clicking on the opt-out link in the email if available. For more information on the processing of your personal data, please check Bruker’s Privacy Policy. 

By submitting this form I agree my personal data will be used to process my registration to the webinar. I have read and accepted the Bruker Website Privacy Notice (https://www.bruker.com/privacy-policy.html) and I agree to the Terms of Use (https://www.bruker.com/terms-of-use.html) of the Bruker website.
Input value is invalid.

Already registered and lost your invitation link?

Just fill in your email and you will receive the link to join/watch the event.

Already registered and lost your invitation link?

Thank you. The invitation link has been resent.